Risk Stratification in Brugada Syndrome

• Published in: Journal of the American College of Cardiology Vol. 59; no. 1; pp. 37 - 45
• Main Authors: Priori, Silvia G., MD, PhD, Gasparini, Maurizio, MD, Napolitano, Carlo, MD, PhD, Della Bella, Paolo, MD, Ottonelli, Andrea Ghidini, MD, Sassone, Biagio, MD, Giordano, Umberto, MD, Pappone, Carlo, MD, Mascioli, Giosuè, MD, Rossetti, Guido, MD, De Nardis, Roberto, MD, Colombo, Mario, MS
• Format: Journal Article
• Language: English
• Published: New York Elsevier Inc 03.01.2012; Elsevier Limited
• Subjects: Brugada syndrome; cardiac arrest; Cardiac arrhythmia; Cardiology; Cardiovascular; Confidence intervals; Deoxyribonucleic acid; DNA; Electrocardiography; electrophysiology; Heart attacks; Internal Medicine; risk factors; ventricular arrhythmias; sustained ventricular tachycardia/ventricular fibrillation; programmed electrical stimulation; risk factors; BrS; Brugada syndrome; CI; ECG; HR; ICD; cardiac arrest; QRS-f; electrocardiogram; electrophysiology; ventricular arrhythmias; VRP; QRS fragmentation; hazard ratio; confidence interval; ventricular refractory period; implantable cardioverter-defibrillator; PES; VTs/VF
• ISSN: 0735-1097; 1558-3597
• DOI: 10.1016/j.jacc.2011.08.064

Objectives The PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) prospective registry was designed to assess the predictive accuracy of sustained ventricular tachycardia/ventricular fibrillation (VTs/VF) inducibility and to identify additional predictors of arrhythmic events in Brugada syndrome patients without history of VT/VF. Background Brugada syndrome is a genetic disease associated with increased risk of sudden cardiac death. Even though its value has been questioned, inducibility of VTs/VF is widely used to select candidates to receive a prophylactic implantable defibrillator, and its accuracy has never been addressed in prospective studies with homogeneous enrolling criteria. Methods Patients with a spontaneous or drug-induced type I electrocardiogram (ECG) and without history of cardiac arrest were enrolled. The registry included 308 consecutive individuals (247 men, 80%; median age 44 years, range 18 to 72 years). Programmed electrical stimulation was performed at enrollment, and patients were followed-up every 6 months. Results During a median follow-up of 34 months, 14 arrhythmic events (4.5%) occurred (13 appropriate shocks of the implantable defibrillator, and 1 cardiac arrest). Programmed electrical stimulation performed with a uniform and pre-specified protocol induced ventricular tachyarrhythmias in 40% of patients: arrhythmia inducibility was not a predictor of events at follow-up (9 of 14 events occurred in noninducible patients). History of syncope and spontaneous type I ECG (hazard ratio [HR]: 4.20), ventricular refractory period <200 ms (HR: 3.91), and QRS fragmentation (HR: 4.94) were significant predictors of arrhythmias. Conclusions Our data show that VT/VF inducibility is unable to identify high-risk patients, whereas the presence of a spontaneous type I ECG, history of syncope, ventricular effective refractory period <200 ms, and QRS fragmentation seem useful to identify candidates for prophylactic implantable cardioverter defibrillator.